Post-effective amendment to a registration statement that is not immediately effective upon filing

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND MEZZANINE EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND MEZZANINE EQUITY - USD ($)
$ in Thousands
Common Stock
Class A Common Stock
Common Stock
Class V Common Stock
Additional Paid in Capital
Accumulated Deficit
Cumulative adjustment due to adoption of new credit loss standard
Accumulated Deficit
Class A Common Stock
Class V Common Stock
Cumulative adjustment due to adoption of new credit loss standard
Total
Increase (Decrease) in Stockholders' Equity                  
Net loss                 $ (146,400)
Ending balance at Dec. 31, 2021                 1,790,617
Increase (Decrease) in Stockholders' Equity                  
Net loss                 (10,081)
Ending balance at Dec. 31, 2021 $ 4 $ 20 $ 312,946   $ (39,418)       273,552
Ending balance (in shares) at Dec. 31, 2021 41,579,000 196,554,000       41,578,890      
Increase (Decrease) in Stockholders' Equity                  
Beginning balance $ 4 $ 20 312,946   (39,418)       273,552
Net loss                 (50,213)
Ending balance at Mar. 31, 2022                 1,752,115
Increase (Decrease) in Stockholders' Equity                  
Vesting of Class V common stock awards (in shares)   549,000              
Equity-based compensation                 11,711
Net loss         (10,577)       (10,577)
Ending balance at Mar. 31, 2022 $ 4 $ 20 312,946   (49,995)       262,975
Ending balance (in shares) at Mar. 31, 2022 41,579,000 197,103,000              
Beginning balance at Dec. 31, 2021                 1,790,617
Ending balance at Dec. 31, 2022                 516,805
Beginning balance (in shares) at Dec. 31, 2021 41,579,000 196,554,000       41,578,890      
Increase (Decrease) in Stockholders' Equity                  
Equity-based compensation     1,786 [1]           1,786
Net loss                 (270,127)
Ending balance at Dec. 31, 2022 $ 4 $ 20 315,375   (309,545)       5,854
Ending balance (in shares) at Dec. 31, 2022 41,579,000 201,592,000       41,578,890 201,592,000    
Increase (Decrease) in Stockholders' Equity                  
Beginning balance $ 4 $ 20 312,946   (49,995)       262,975
Beginning balance 4 $ 20 315,375   (309,545)       5,854
Equity-based compensation                 291
Net loss                 (43,249)
Ending balance at Mar. 31, 2023               $ (124) 473,723
Increase (Decrease) in Stockholders' Equity                  
Vesting of Class V common stock awards (in shares)   275,000              
Equity-based compensation     686           686
Net loss         (9,199)       (9,199)
Ending balance at Mar. 31, 2023 $ 4 $ 20 316,061 $ (26) (318,770)     (26) (2,685)
Ending balance (in shares) at Mar. 31, 2023 41,579,000 201,867,000       41,579,000 201,867,000    
Increase (Decrease) in Stockholders' Equity                  
Beginning balance $ 4 $ 20 $ 316,061 $ (26) $ (318,770)     $ (26) $ (2,685)
[1] Included in the opening balance are transactions completed in connection with the Business Combinations (Note 5), including the PIPE Investment (Note 1) of $195.3 million (net of issuance costs), the equity consideration to P3 shareholders of $80.3 million, and the trust proceeds (net of redemptions) of $37.4 million.